08.08.2022 • NewsKBRmcdermottammonia

McDermott and KBR in Ammonia Pact

Engineering companies McDermott International and KBR have entered into a global licensing agreement to provide integrated solutions for KBR's proprietary ammonia technologies.

The US multinational groups said the combination of KBR's technology with McDermott's execution capabilities and fabrication and modularization expertise “represents a compelling solution to meet the growing ammonia market.”

"This agreement enables us to offer customers an integrated approach for low-carbon ammonia projects by combining KBR's best-in-class ammonia technology with our global project delivery know-how, low-carbon execution approach and leadership in ammonia storage solutions," said Tareq Kawash, McDermott’s senior vice president, onshore. The partnership, he added,” is an important addition to our growing energy transition portfolio and strengthens our concept-to-completion capabilities."

As part of the arrangement, McDermott and KBR will jointly evaluate opportunities to provide modularized execution concepts for green and blue ammonia projects. Ammonia produced from renewable or low-carbon sources – referred to as green and blue ammonia – can be used to provide carbon-free fertilizers, as an energy carrier or as a fuel.

Author: Elaine Burridge, Freelance Journalist

© iamporpla/Shutterstock
© iamporpla/Shutterstock

Special Issue

Circular Plastics Economy
Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read